Day: March 20, 2026

Evidence of Efficacy and Safety of Deucrictibant for Prophylaxis and On-Demand Treatment of Hereditary Angioedema Attacks Published Back-to-Back in The Lancet Haematology

Results from Phase 2 clinical studies, CHAPTER-1 and RAPIDe-1, provide evidence of viability of bradykinin B2 receptor antagonism in management...

Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity

David Meeker Quote David Meeker Quote Dr. Shoemaker quote Dr. Shoemaker quote IMCIVREE packaging IMCIVREE packaging with vial IMCIVREE 3D...

error: Content is protected !!